Sangamo Therapeutics

In News

Sangamo to put ‘substantially all’ assets for sale in bankruptcy, lines up Lilly and Astellas as buyers - Fierce Biotech

Fierce Biotech - Jun 23, 2026

Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders - Yahoo Finance

Yahoo Finance - Jun 08, 2026

Sangamo Therapeutics (SGMO) Q2 2025 earnings summary - Quartr

Quartr - Jul 14, 2026

Biotech firm files for bankruptcy with $115M debt; Eli Lilly, Astellas bet on it anyway - MassLive

MassLive - Jun 24, 2026

UPDATE: Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy - BioSpace

BioSpace - Jun 23, 2026

Gene Editing Pioneer Sangamo Files for Chapter 11 Bankruptcy; Agrees to Sell Assets - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Jun 23, 2026

Inside Sangamo Therapeutics' bankruptcy: Dwindling choices, millions of dollars, more layoffs - The Business Journals

The Business Journals - Jun 24, 2026

SGMOQ: Sangamo Therapeutics - Full Company Report - Zacks Investment Research

Zacks Investment Research - Jul 11, 2026

A Gene-Therapy Pioneer Just Filed For Chapter 11 Bankruptcy—Now Eli Lilly Wants Its Tech - inc.com

inc.com - Jun 24, 2026

Sangamo Therapeutics (SGMO) Q4 2024 earnings summary - Quartr

Quartr - Jul 14, 2026

Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas - Yahoo Finance

Yahoo Finance - Jun 23, 2026

Layoff Tracker: EMD Serono may trim R&D workforce by up to 70 - BioSpace

BioSpace - Jul 13, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment